Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 197 publications
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 28, 2026
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 23, 2025
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): Results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 23, 2025
AstroID resource: a scalable, relational database structure for longitudinal biomarker discovery.
Journal: Journal for immunotherapy of cancer
Published: November 20, 2025
Clinical outcomes by type of surgery with perioperative durvalumab in patients with resectable non-small cell lung cancer.
Journal: The Journal of thoracic and cardiovascular surgery
Published: November 06, 2025
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.
Journal: Nature
Published: November 04, 2025
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C.
Journal: ESMO open
Published: October 02, 2025
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
Journal: Nature medicine
Published: August 29, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.
Journal: Journal of translational medicine
Published: August 22, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Last Updated: 09/26/2026